"Sedative and cardiovascular effects of clonidine and nitrazepam". Clin Pharmacol Ther. 28 (2): 167–76. August 1980. doi:10.1038/clpt.1980.146. PMID7398184.
"Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines". JAMA: the Journal of the American Medical Association. 241 (16): 1692–5. April 20, 1979. doi:10.1001/jama.241.16.1692. PMID430730.
"Effects of single doses of propiomazine, a phenothiazine hypnotic, on sleep and oxygenation in patients with stable chronic obstructive pulmonary disease". Respiration. 57 (4): 239–42. 1990. doi:10.1159/000195848. PMID1982774.
"Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam". Sleep Med. 9 (8): 818–22. Dec 2008. doi:10.1016/j.sleep.2007.11.011. PMID18226959.
"Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin". Psychiatry and clinical neurosciences. 50 (6): 337–9. December 1996. doi:10.1111/j.1440-1819.1996.tb00577.x. PMID9014234.
"Behavioural effects of a benzodiazepine receptor partial agonist, Ro 19-8022, in the social conflict test in mice". Behavioural Pharmacology. 11 (2): 143–51. 2000. doi:10.1097/00008877-200004000-00006. PMID10877119.
"Studies on the involvement of opioid mechanism in the locomotor effects of benzodiazepines in rats". Pharmacology, Biochemistry, and Behavior. 38 (2): 265–6. February 1991. doi:10.1016/0091-3057(91)90276-8. PMID1676167.
"Effect of 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, on cerebral content of neuroactive amino acids". Jpn J Pharmacol. 39 (4): 558–61. December 1985. doi:10.1254/jjp.39.558. PMID2869172.
"Human pharmacokinetics of nitrazepam: effect of age and diseases". Human pharmacokinetics of nitrazepam: effect of age and diseases. 15 (3): 163–70. April 1979. doi:10.1007/bf00563100. PMID456400.
"Plasma nitrazepam concentrations after an acute intake and their correlation to sedation and serum growth hormone levels". Acta Pharmacol Toxicol (Copenh). 41 (1): 65–73. July 1977. doi:10.1111/j.1600-0773.1977.tb02124.x. PMID331868.
"Benzodiazepines in the treatment of epilepsy in people with intellectual disability". J Intellect Disabil Res. 42 (1): 80–92. December 1998. PMID10030438.
"Sedative and cardiovascular effects of clonidine and nitrazepam". Clin Pharmacol Ther. 28 (2): 167–76. August 1980. doi:10.1038/clpt.1980.146. PMID7398184.
Străulea AO, Chiriţă V (July–September 2009). "[The withdrawal syndrome in benzodiazepine dependence and its management]". Rev Med Chir Soc Med Nat Iasi. 113 (3): 879–84. PMID20191849.
"Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines". JAMA: the Journal of the American Medical Association. 241 (16): 1692–5. April 20, 1979. doi:10.1001/jama.241.16.1692. PMID430730.
"Effects of single doses of propiomazine, a phenothiazine hypnotic, on sleep and oxygenation in patients with stable chronic obstructive pulmonary disease". Respiration. 57 (4): 239–42. 1990. doi:10.1159/000195848. PMID1982774.
"Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam". Sleep Med. 9 (8): 818–22. Dec 2008. doi:10.1016/j.sleep.2007.11.011. PMID18226959.
"Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin". Psychiatry and clinical neurosciences. 50 (6): 337–9. December 1996. doi:10.1111/j.1440-1819.1996.tb00577.x. PMID9014234.
"Comparative effects of rifampin and/or probenecid on the pharmacokinetics of temazepam and nitrazepam". Int J Clin Pharmacol Ther Toxicol. 28 (9): 387–93. September 1990. PMID2228325.
"Pharmacologic studies of central actions of zopiclone: influence on brain monoamines in rats under stressful condition". Int J Clin Pharmacol Ther Toxicol. 23 (4): 204–10. April 1985. PMID2860074.
"Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture". J Pharmacol Exp Ther. 244 (2): 789–95. February 1988. PMID2450203.
"Investigation of the muscle relaxant activity of nitrazepam". Arch Int Pharmacodyn Ther. 272 (1): 129–39. November 1984. PMID6517646.
"Behavioural effects of a benzodiazepine receptor partial agonist, Ro 19-8022, in the social conflict test in mice". Behavioural Pharmacology. 11 (2): 143–51. 2000. doi:10.1097/00008877-200004000-00006. PMID10877119.
"Studies on the involvement of opioid mechanism in the locomotor effects of benzodiazepines in rats". Pharmacology, Biochemistry, and Behavior. 38 (2): 265–6. February 1991. doi:10.1016/0091-3057(91)90276-8. PMID1676167.
"Effect of 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, on cerebral content of neuroactive amino acids". Jpn J Pharmacol. 39 (4): 558–61. December 1985. doi:10.1254/jjp.39.558. PMID2869172.
"Human pharmacokinetics of nitrazepam: effect of age and diseases". Human pharmacokinetics of nitrazepam: effect of age and diseases. 15 (3): 163–70. April 1979. doi:10.1007/bf00563100. PMID456400.
Vozeh S (November 21, 1981). "[Pharmacokinetic of benzodiazepines in old age]". Schweiz Med Wochenschr. 111 (47): 1789–93. PMID6118950.
"Plasma nitrazepam concentrations after an acute intake and their correlation to sedation and serum growth hormone levels". Acta Pharmacol Toxicol (Copenh). 41 (1): 65–73. July 1977. doi:10.1111/j.1600-0773.1977.tb02124.x. PMID331868.